Director, Scientific ConsultingXcenda, AmerisourceBergenCarrollton, Texas, United States
PB0022 - Impact of COVID-19 on thromboembolic events and mortality among patients with non-valvular atrial fibrillation receiving oral anticoagulants
Sunday, June 25, 202318:30 – 19:30 ET
PB0324 - Burden of Symptoms and Healthcare Resource Utilization (HCRU) and Costs in U.S. Patients with Thrombotic Thrombocytopenic Purpura (TTP)